Failure to find associations of the CA repeat polymorphism in the first intron and the Gly(-63)/Glu(-63) polymorphism of the neurotrophin-3 gene with schizophrenia

被引:10
作者
Arinami, T
Takekoshi, K
Itokawa, M
Hamaguchi, H
Toru, M
机构
[1] UNIV TSUKUBA, INST BASIC MED SCI, DEPT MED GENET, TSUKUBA, IBARAKI 305, JAPAN
[2] UNIV TSUKUBA, INST CLIN MED, DEPT CLIN PATHOL, TSUKUBA, IBARAKI 305, JAPAN
[3] TOKYO MED & DENT UNIV, DEPT NEUROPSYCHIAT, TOKYO 113, JAPAN
关键词
association study; CA repeat polymorphism; Gly-63Glu polymorphism; neurotrophin-3; schizophrenia;
D O I
10.1097/00041444-199621000-00003
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This study aimed to replicate positive associations between polymorphisms of the neurotrophin-3 gene and schizophrenia, The reported associations, which were the results of searching for mutations in the locus in schizophrenics under the hypothesis of neurodevelopmental etiology of schizophrenia, are that the states carrying the (CA)(23) allele of the CA repeat in the first intron have a 2.56-fold increased risk of schizophrenia and those carrying the allele Glu(-63) instead of Cry(-63) have a 2.6-fold increased risk of schizophrenia with onset before 25 years and with duration of the illness of more than 10 years. We analyzed these polymorphisms in 80 schizophrenics with onset before 25 years of age and with duration of illness of more than 10 years and 80 age-matched psychosis-free controls. With our sample size, there was a 90% chance of detecting odds ratios observed in initial positive reports. We found similar allele and genotype frequencies of both polymorphisms between the schizophrenic and control groups. We failed to support associations between the polymorphisms of the neurotrophin-3 gene analyzed and schizophrenia.
引用
收藏
页码:13 / 15
页数:3
相关论文
共 6 条
  • [1] The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder
    Bouffard, R
    Hechtman, L
    Minde, K
    Iaboni-Kassab, F
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08): : 546 - 554
  • [2] Cohen J., 1988, Statistical Power Analysis for the Behavioral Sciences, V2
  • [3] DINUCLEOTIDE REPEAT POLYMORPHISM IN THE PROMOTER REGION OF NEUROTROPHIN-3 GENE (NT3)
    HATTORI, M
    KUWATA, S
    FUKUDA, R
    SASAKI, T
    SHIBATA, Y
    KAZAMATSURI, H
    NANKO, S
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (09) : 1511 - 1511
  • [4] ASSOCIATION OF NEUROTROPHIN-3 GENE VARIANT WITH SEVERE FORMS OF SCHIZOPHRENIA
    HATTORI, M
    NANKO, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (02) : 513 - 518
  • [5] HUMAN AND RAT BRAIN-DERIVED NEUROTROPHIC FACTOR AND NEUROTROPHIN-3 - GENE STRUCTURES, DISTRIBUTIONS, AND CHROMOSOMAL LOCALIZATIONS
    MAISONPIERRE, PC
    LEBEAU, MM
    ESPINOSA, R
    IP, NY
    BELLUSCIO, L
    DELAMONTE, SM
    SQUINTO, S
    FURTH, ME
    YANCOPOULOS, GD
    [J]. GENOMICS, 1991, 10 (03) : 558 - 568
  • [6] NEUROTROPHIN-3 GENE POLYMORPHISM ASSOCIATED WITH SCHIZOPHRENIA
    NANKO, S
    HATTORI, M
    KUWATA, S
    SASAKI, T
    FUKUDA, R
    DAI, XY
    YAMAGUCHI, K
    SHIBATA, Y
    KAZAMATSURI, H
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 (06) : 390 - 392